Investigating the anticancer and anti-angiogenic effects of graphene oxide nanoparticles containing 6-gingerol modified with chitosan and folate
Tóm tắt
The use of nanocarriers to improve the targeting of treatment plays a key role in the treatment of many diseases, including cancer. This study was carried out to synthesize graphene oxide (GO) containing 6-gingerol (Ging) modified with chitosan (CS)-folic acid (FA) nanoparticles (Ging-GO-CS-FA) to improve the anti-cancer effects of Ging. After the synthesis of nanoparticles, the average size, surface charge, and dispersion index (DPI) of nanoparticles were analyzed by the dynamic light scattering (DLS) method. Field emission scanning electron microscope (FESEM) and Fourier transform infrared spectroscopy (FTIR) were utilized to assess the morphology and functional groups of synthesized nanoparticles, respectively. The 2,5-diphenyl-2H-tetrazolium bromide (MTT) method was performed to assess the toxicity effect of nanoparticles on different types of cancer cells. The antioxidant power of nanoparticles was evaluated by ABTS and DPPH methods. In addition, the chorioallantoic membrane (CAM) test was conducted to investigate the anti-angiogenic effects of nanoparticles. Finally, the real-time quantitative PCR (qPCR) method was carried out to detect the changes in the expression of angiogenic and antioxidant genes in cancer cells. The nanoparticles have an average size of 73.21 nm, a DPI of 0.27, and a surface charge of 29.5. The encapsulation rate of Ging in nanoparticles was reported to be 81.7%. According to the MTT test, the most sensitive cell line to the Ging-GO-CS-FA nanoparticles was reported to be gastric cancer cells (IC50 ~ 27). The results of the antioxidant test showed the high antioxidant power of nanoparticles in the laboratory environment by inhibiting ABTS and DPPH free radicals. The pro-oxidant power of Ging-GO-CS-FA against cancer cells was confirmed by reducing the amount of the superoxide dismutase (SOD) gene in the treated cells. The decreasing effects of Ging-GO-CS-FA on angiogenesis were observed by reducing the average length, the number of blood vessels, average height, and weight of treated embryos. In addition, the decrease in the expression of VEGF and VEGF-R genes confirmed the anti-angiogenic of Ging-GO-CS-FA. These results show the promising effect of Ging-GO-CS-FA on gastric cancer cells by inhibiting angiogenesis and increasing the level of oxidants.
Tài liệu tham khảo
Campbell E, Hasan MT, Pho C, Callaghan K, Akkaraju GR, Naumov AV (2019) Graphene oxide as a multifunctional platform for intracellular delivery, imaging, and cancer sensing. Sci Rep 9(1):416
Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4–10
Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ (2016) Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Colloids Surf B 138:1–9
Compton OC, Nguyen ST (2010) Graphene oxide, highly reduced graphene oxide, and graphene: versatile building blocks for carbon-based materials. Small 6(6):711–723
de Sousa M, Visani de Luna LA, Fonseca LC, Giorgio S, Alves OL (2018) Folic-acid-functionalized graphene oxide nanocarrier: synthetic approaches, characterization, drug delivery study, and antitumor screening. ACS Appl Nano Mater 1(2):922–932
Dimiev AM, Tour JM (2014) Mechanism of graphene oxide formation. ACS Nano 8(3):3060–3068
Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR (2019) Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomed 14(1):93–126
Farjadian F, Abbaspour S, Sadatlu MAA, Mirkiani S, Ghasemi A, Hoseini-Ghahfarokhi M, Mozaffari N, Karimi M, Hamblin MR (2020) Recent developments in graphene and graphene oxide: properties, synthesis, and modifications: a review. ChemistrySelect 5(33):10200–10219
Feng L, Wu L, Qu X (2013) New horizons for diagnostics and therapeutic applications of graphene and graphene oxide. Adv Mater 25(2):168–186
Gaur M, Misra C, Yadav AB, Swaroop S, Maolmhuaidh F, Bechelany M, Barhoum A (2021) Biomedical applications of carbon nanomaterials: fullerenes, quantum dots, nanotubes, nanofibers, and graphene. Materials 14(20):5978
Hamedinasab H, Rezayan AH, Mellat M, Mashreghi M, Jaafari MR (2020) Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine. Int J Biol Macromol 156:1455–1463
Haque MU, Ferdiousi N, Sajon SR (2016) Anticancer agents derived from plant and dietary sources: a review. Int J Pharmacogn 3:55–66
Itoo AM, Vemula SL, Gupta MT, Giram MV, Kumar SA, Ghosh B, Biswas S (2022) Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Controlled Release 350:26–59
Jain KK (2020) Role of nanobiotechnology in drug delivery. Drug Deliv Syst 2059:55–73
Keklikcioglu Cakmak N, Eroglu A (2023) Doxorubicin and tamoxifen loaded graphene oxide nanoparticle functionalized with chitosan and folic acid for anticancer drug delivery. Polym Bull 80(2):2171–2185
Khurana R, Simons M, Martin JF, Zachary IC (2005) Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112(12):1813–1824
Kim EC, Min JK, Kim TY, Lee SJ, Yang HO, Han S, Kim YM, Kwon YG (2005) [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 335(2):300–308
Kovalchuk O, Kovalchuk I (2020) Cannabinoids as anticancer therapeutic agents. Cell Cycle 19(9):961–989
Liang L, Wang J, Lin W, Sumpter BG, Meunier V, Pan M (2014) Electronic bandgap and edge reconstruction in phosphorene materials. Nano Lett 14(11):6400–6406
Liu Z, Robinson JT, Sun X, Dai H (2008) PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130(33):10876–10877
Liu J, Cui L, Losic D (2013) Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 9(12):9243–9257
Low PS, Henne WA, Doorneweerd DD (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41(1):120–129
Lu B, Lv X, Le Y (2019) Chitosan-Modified PLGA nanoparticles for control-released drug delivery. Polymers 11(2):304
Mashreghi M, Azarpara H, Bazaz MR, Jafari A, Masoudifar A, Mirzaei H, Jaafari MR (2018) Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. J Cell Physiol 233(4):2949–2965
McCallion C, Burthem J, Rees-Unwin K, Golovanov A, Pluen A (2016) Graphene in therapeutics delivery: problems, solutions and future opportunities. Eur J Pharm Biopharm 104:235–250
Mokhtareeizadeh Z, Homayouni Tabrizi M (2022) Optimisation of ferula assa-foetida -loaded PLGA Nanoparticles synthesised and evaluation of putative mechanism for anticancer properties. Mater Technol 37(11):1954–1967
Mukherjee S, Sriram P, Barui AK, Nethi SK, Veeriah V, Chatterjee S, Suresh KI, Patra CR (2015) Graphene oxides show angiogenic properties. Adv Healthc Mater 4(11):1722–1732
Mukherjee A, Madamsetty VS, Paul MK, Mukherjee S (2020) Recent advancements of nanomedicine towards antiangiogenic therapy in cancer. Int J Mol Sci 21(2):455
Mura P, Maestrelli F, Cirri M, Mennini N (2022) Multiple roles of chitosan in mucosal drug delivery: an updated review. Mar Drugs 20(5):335
Pashaei-Asl R, Pashaei-Asl F, Mostafa Gharabaghi P, Khodadadi K, Ebrahimi M, Ebrahimie E, Pashaiasl M (2017) The Inhibitory Effect of Ginger Extract on Ovarian Cancer Cell line; application of Systems Biology. Adv Pharm Bull 7(2):241–249
Rabea EI, Badawy ME-T, Stevens CV, Smagghe G, Steurbaut W (2003) Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 4(6):1457–1465
Sp N, Kang DY, Lee JM, Bae SW, Jang KJ (2021) Potential antitumor effects of 6-gingerol in p53-dependent mitochondrial apoptosis and inhibition of tumor sphere formation in breast cancer cells. Int J Mol Sci 22(9):4460
Tagde P, Kulkarni GT, Mishra DK, Kesharwani P (2020) Recent advances in folic acid engineered nanocarriers for treatment of breast cancer. J Drug Deliv Sci Technol 56:101613
Tran AV, Shim K, Vo Thi TT, Kook JK, An SSA, Lee SW (2018) Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers. Acta Biomater 74:397–413
Unger WW, van Beelen AJ, Bruijns SC, Joshi M, Fehres CM, van Bloois L, Verstege MI, Ambrosini M, Kalay H, Nazmi K et al (2012) Glycan-modified liposomes boost CD4 + and CD8 + T-cell responses by targeting DC-SIGN on dendritic cells. J Controll Release 160(1):88–95
Wang S, Zhang C, Yang G, Yang Y (2014) Biological properties of 6-gingerol: a brief review. Nat Prod Commun 9(7):1027–1030
Wang F, Yuan J, Zhang Q, Yang S, Jiang S, Huang C (2018) PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy. J Biomater Sci Polym Ed 29(13):1566–1578
Xiong J, Yang Q, Li J, Zhou S (2014) Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer. Angiogenesis 17:37–50
Zangabad PS, Mirkiani S, Shahsavari S, Masoudi B, Masroor M, Hamed H, Jafari Z, Taghipour YD, Hashemi H, Karimi M et al (2018) Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications. Nanatechnol reviews 7(1):95–122
Zarei B, Tabrizi MH, Rahmati A (2022) PEGylated Lecithin-Chitosan nanoparticle–encapsulated Alphα-Terpineol for in Vitro Anticancer Effects. AAPS PharmSciTech 23(4):94
Zhang M, Zhao R, Wang D, Wang L, Zhang Q, Wei S, Lu F, Peng W, Wu C (2021) Ginger (Zingiber officinale Rosc.) And its bioactive components are potential resources for health beneficial agents. Phytother Res 35(2):711–742